Source link : https://newshealth.biz/health-news/adding-menin-inhibitor-promising-in-certain-aml-patients/
(MedPage Today) — Adding the menin inhibitor revumenib (Revuforj) to azacitidine and venetoclax (Venclexta) seemed to benefit older adults with newly diagnosed NPM1-mutated or KMT2A-rearranged acute myeloid leukemia (AML), according to results… Source link : https://www.medpagetoday.com/meetingcoverage/eha/116071 Author : Publish date : 2025-06-13 18:01:00 Copyright for syndicated content belongs to the linked Source.
The post Adding Menin Inhibitor Promising in Certain AML Patients first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-13 18:01:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8